Skip to main content

ECHA adds four to Candidate List

22nd July 2019

Submitted by:

Andrew Warmington

The European Chemicals Agency has added four new substances to the Candidate List of substances of very high concern (SVHCs) for authorisation under REACH. This brings the total number to 201.

The four include 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionic acid (HFPO-DA), its salts and its acyl halides, which are used as processing aids in the production of fluorinated polymers. They have been added on the basis of an ‘equivalent level of concern, having probable serious effects to the environment’.

The Member State Committee (MSC) had agreed on 27 June with a proposal by the Netherlands to add HFPO-DA because of its “high potential to cause effects in wildlife and in humans through the environment due to its very high persistence, mobility in water, potential for long-range transport, accumulation in plants and observed effects on human health and the environment”.

Also added were: 2-methoxyethyl acetate, a reprotoxic substance which had not been registered under REACH; and two endocrine disrupters: the antioxidant tris(4-nonylphenyl, branched and linear) phosphite (TNPP) with ≥ 0.1% w/w of 4-nonylphenol, branched and linear (4-NP), and 4-tert-butylphenol, which is mainly used in coating products.

Manufacturers and importers now have until 16 January 2020 to inform ECHA, downstream users and, on request, consumer of any articles containing >0.1% w/w of these substances. If and when they reach the Authorisation List, industry must apply for permission to continue using them after a specified ‘sunset date’.

Shortly before this, ECHA had prepared a recommendation to amend the Authorisation List to include endocrine disrupting properties for four phthalate plasticisers which were already on it for other reasons: DEHP, BBP, DBP and DIBP. This followed a long process of public consultation and evaluation by the MSC.

As a result, the limit for their use in mixtures in concentrations has been reduced from 0.3% to 0.1 % w/w and some uses of DEHP, notably food contact materials and medical devices, will no longer fall under the ‘generic exemptions’ category. The agency has also invited the European Commission to review the existing exemption for uses of BBP and DBP in immediate packaging of medicinal products.

ECHA has also said that it will start to evaluate 20% of REACH registration dossiers in each tonnage band, meaning that about 30% of all registered substances will be checked. This is part of a joint action plan with the EC to “address the lack of compliance in registration dossiers and encourage industry to improve their safety data on chemicals”. Currently, the minimum target is 5%.

The stated aim is to screen all registration dossiers submitted by the 2018 deadline: by 2023 for substances registered over 100 tonnes/year and by 2027 for substances in 1-100 tonnes/year band. For high tonnage substances, ECHA will conclude by the end of 2020 whether they are a priority for risk management, for data generation or of low priority for further action.

Separately, ECHA has announced that it has started working on various tasks to identify and regulate persistent organic pollutants (POPs) under the revised POPs Regulation. These include identifying new POP substances, acting as an interface for reporting duties on implementing the Regulation and promoting an exchange of information internally and externally. 

Feature article – Saltigo rides out the cycle

Market and sustainability trends are positive drivers for Saltigo, despite the agro downturn. Andrew Warmington met up with the new CEO at Chemspec Europe

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical active ingredient (AI) manufacturing to its wholly owned subsidiary UPL Spec

Submitted by:

Andrew Warmington

Nippon Shokubai opens Indonesian plant

Japan’s Nippon Shokubai has officially opened a 100,000 tonnes/year acrylic acid (AA) plant that was built at a cost of about $200 million at Cilegon, Banten, Indonesia.

Submitted by:

Andrew Warmington

CABB to invest at Finnish agro site

The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland.

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production planning of superabsorbent polymers (SAPs) based on acrylic acid, and has started operati

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after a week after the latter declined to engage with it.

Submitted by:

Andrew Warmington

adcs

Three invest further into ADCs

Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.

Submitted by:

Andrew Warmington

Cambrex exits drug product

CDMO Cambrex has sold its Drug Product business unit to Noramco. Terms were not disclosed.

Submitted by:

Andrew Warmington

Siegfried breaks ground on R&D centre

Siegfried has broke ground for its new global R&D centre for drug substances at its site in Evionnaz, Switzerland.

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants under the trade names AmphiCare and AmphiClean.

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based subsidiary of Seqens.

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in Austria have co-developed a computer-assisted regression model to improve enzyme performance and

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bi

Submitted by:

Andrew Warmington

Investment in Tanasote plant

Octowood, a part of the Sweden’s Rundvirke Industrier Group, has invested in a new treatment plant using Arxada’s wood preservative, Tanasote.

Submitted by:

Andrew Warmington

Rhamnolipid milestone reached

Evonik has manufactured the first product from its industrial-scale biosurfactants facility at Slovenská Lupca in Slovakia.

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach Group in a move that it said would “create a global pigment company, combining SCIL’s ope

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen site in Germany, preserving 50 jobs there.

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw materials, has announced a strategic collaboration with Japan’s Takasago, a large player in th

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site in Guangzhou. This triples its manufacturing capacity for fragrances and establis

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes i

Submitted by:

Andrew Warmington

Kao boosts jasmine fragrance

Japan's Kao Corporation is to double capacity for the synthetic fragrance methyl dihydrojasmonate (MDJ) at its site in Olesa, Spain, by adding a second production facility.

Submitted by:

Andrew Warmington

Merck KGaA “in a strong strategic position”

At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitio

Submitted by:

Andrew Warmington

Suez joins Global Impact Coalition

Suez, which describes itself as “a global leader in circular solutions for water and waste”, has joined the Global Impact Coalition (GIC).

Submitted by:

Andrew Warmington

Chemours opens battery lab

Chemours has opened Chemours Battery Innovation Centre (CBIC) at the Chemours Discovery Hub in Newark, Delaware.

Submitted by:

Andrew Warmington